AI synthetic patients successfully replace real trial controls
A new study shows AI-generated synthetic patients can replicate cancer trial results, potentially shrinking the need for human control groups.
July 17, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🎗 Oncology.
AI Tool Predicts Cancer Survival From Single Cells
Averaging tumor data has long blinded oncologists to the specific, high-risk cells that drive patient mortality.
July 14, 2026
ML predicts fertility-sparing treatment success in cancer
A new machine learning model uses simple blood and nutrition markers to predict which uterine cancer patients can safely skip aggressive surgery to preserve their fertility.
July 13, 2026
AI Detects Blood Cancers From Routine Blood Tests
A new AI model turns the standard complete blood count into an instant classifier for leukemia and severe infections, bypassing the slow manual slide review that delays critical care.
July 13, 2026
AI tackles the prostate MRI bottleneck
Doubling scanning capacity is useless if there are no radiologists left to read the scans.
July 11, 2026
AI blood test spares women invasive cancer scans
A new AI-driven blood test could soon keep thousands of women out of the imaging room by ruling out womb cancer with near-perfect accuracy.
July 9, 2026
FDA clears self-updating radiation planning software
A new regulatory shortcut could quietly solve the worst bottleneck in cancer treatment.
July 6, 2026
AI Outperforms Doctors on Cancer Reports
When algorithms read pathology reports better than the oncologists who ordered them, the bottleneck in cancer care shifts from diagnostic accuracy to human administrative capacity.
July 6, 2026
AI predicts kidney cancer immunotherapy survival rates
A new machine learning model uses basic blood markers to predict how kidney cancer patients respond to immunotherapy.
July 5, 2026
Cheap DNA sequencing detects ovarian cancer
By combining two different genomic signals, researchers proved that cheap, shallow DNA sequencing can catch ovarian cancer with high accuracy.
July 4, 2026